Classement en actions
#33056
Arctic Bioscience AS, a clinical-stage biotechnology company, engages in... Arctic Bioscience AS, a clinical-stage biotechnology company, engages in developing and commercializing pharmaceutical and nutraceutical ingredients based on bioactive marine compounds in Norway, the United States, Europe, and Asia Pacific. The company is developing HRO350, a novel oral drug which is in phase IIb for the treatment of mild-to-moderate psoriasis. It also sells nutraceuticals as intermediary and finished goods products under the ROMEGA brand name. Arctic Bioscience AS was incorporated in 2011 and is headquartered in Ørsta, Norway.
Prix de l'action
$0.3144463
Capitalisation boursière
$8.48M
Changement (1 jour)
0.00%
Échange Arctic Bioscience AS (ABS)
Le prix ABS avec la capitalisation boursière de B
Capitalisation boursière de Arctic Bioscience AS(ABS)
Capitalisation boursière: $8.48M
En August 2026, Arctic Bioscience AS a une capitalisation boursière de $8.48M. Cela fait de Arctic Bioscience AS la 33056th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Arctic Bioscience AS du 2021 au 2026
ABS par rapport au top 5 des plus populaires stocks
| Prix pour ABS |
|
L’actif B |
La capitalisation boursière de B |
Résultats |
|
|
|
|
$5.452T
|
+64,316,476.23%
|
|
|
|
|
$4.504T
|
+53,133,148.54%
|
|
|
|
|
$4.169T
|
+49,186,106.60%
|
|
|
|
|
$3.676T
|
+43,370,313.65%
|
|
|
|
|
$2.833T
|
+33,421,767.68%
|
